Introduction
Intracranial dural arteriovenous fistulas (AVFs) represent 10%-15% of all intracranial vascular malformations. Although dural AVFs can occur anywhere in the dura mater covering the brain, they occur most frequently in the cavernous and transversesigmoid sinuses (Fig 1) . Patients may be asymptomatic or may experience symptoms ranging from mild symptoms to fatal hemorrhage. Furthermore, these symptoms may be characterized as either nonaggressive (benign) (eg, tinnitus) or aggressive (eg, intracranial hemorrhage, neurologic deficits) ( Table  1 ) (1) (2) (3) (4) . For many years, researchers have attempted to identify the factors that predispose to the risk of aggressive dural AVF symptoms (3) (4) (5) (6) (7) (8) (9) . On the basis of their findings, it is now generally accepted that the venous drainage pattern of dural AVFs is the most predictive factor (3,4,7,9 -11) . Although several classification systems have been developed to grade the risks of dural AVFs, those devised by Cognard et al (3) and Borden et al (8) are the most widely used (Tables 2, 3 ). Dural AVFs that drain via the retrograde leptomeningeal cortical venous drainage channel show a significantly high rate of aggressive symptoms. Although dural AVF location is not directly correlated with aggressive behavior, the propensity for dangerous drainage patterns found at initial diagnosis does vary with location (3) . Difficulties associated with treatment methods and proposed techniques, including limited access during interventional and surgical procedures, also differ depending on location: They are similar for dural AVFs of the transverse-sigmoid sinus and superior sagittal sinus and are unique for dural AVFs of the cavernous sinus, tentorium, and anterior fossa. Furthermore, the efficacy of irradiation also differs depending on location and drainage pattern.
In this article, we discuss and illustrate general approaches to the treatment of dural AVFs. We also discuss current strategies in the treatment of dural AVFs based on location (cavernous sinus, transverse-sigmoid sinus, tentorium, superior sagittal sinus, anterior fossa) and drainage pattern, as well as alternative techniques of curative transcatheter embolization. We reviewed 32 cases of dural AVF from the past 5 years using diagnostic and interventional record databases and surgical records at our institutions.
General Treatment Approaches
General approaches for the treatment of dural AVFs include conservative treatment, radiation therapy, endovascular intervention, and surgery.
Conservative Treatment
The spontaneous regression of dural AVFs has been reported (12) (13) (14) . Such an observation, which might be caused by thrombosis of the sinus or fistula, is frequently associated with cavernous sinus dural AVFs; therefore, some dural AVFs can be treated conservatively.
Radiation Therapy
Recent studies of the efficacy of stereotactic radiosurgery have reported relatively good results, with complete occlusion in 44%-87% of cases without serious complications (15) (16) (17) (18) (19) (20) (21) (22) (23) . Advantages of this technique include decreased invasiveness and fewer short-term complications, whereas a disadvantage is the delayed response (approximately 6 -12 months) after irradiation. The combined use of stereotactic radiosurgery and transarterial embolization (TAE) with particles can enhance the effectiveness of this technique and reduce the risk of worsening symptoms during the follow-up period (18, 19, 23) .
Endovascular Intervention
TAE with Particles.-Feeding artery embolization of external carotid branches with particles is easily performed and can reduce shunt flow. However, complete cures are difficult to achieve with this method because of the existence of feeding arteries that cannot be catheterized and the recruitment of a blood supply from collateral arteries (24) . Therefore, this method is generally used to relieve symptoms or in combination with other procedures such as irradiation, surgery, or transvenous embolization (TVE). retically, the radial force of the stent can restore antegrade sinus flow and close shunts within the sinus wall. Although some dural AVFs have been successfully treated with stents, the long-term results are not yet known. Furthermore, currently available stents with sufficient diameter are relatively large (over 6 F) and have a stiff shaft. It is often difficult to introduce the stent into the affected area of the sinus due to the acute angle of the sigmoid sinus and the irregular narrowing of the lesion.
Surgery.-Thanks to recent technical developments, interventional procedures have become a first-line treatment for dural AVFs. However, some difficult cases require surgical techniques (eg, sinus isolation and resection) in combination with interventional procedures; indeed, other cases, especially those involving dural AVFs of the anterior cranial fossa, can often be treated more easily and safely with surgical disconnection of the venous drainage (33) .
Cavernous Sinus Dural AVFs
The most common symptoms of cavernous sinus dural AVF are ocular symptoms (eg, exophthalmos [proptosis]) caused by anterior venous drainage (Fig 3) (blindness) (24, 25) . Spontaneous regression of cavernous sinus dural AVFs is well recognized, being observed in 10%-50% of cases (2,13).
Treatment Strategy
Treatment options include conservative treatment, irradiation, TAE with particles or cyanoacrylate, and TVE. Recent studies of stereotactic radiation therapy for cavernous sinus dural AVFs showed a relatively high occlusion rate for the AVF (70%-88%) several months after treatment without significant complications (15, 20, 23) . TVE and TAE with n-butyl-2-cyanoacrylate showed a higher occlusion rate (80%-100%) immediately after the procedure; however, serious complications such as intracranial hemorrhage and cranial nerve deficits were also reported (25) (26) (27) 35, 36) . The efficacy, potential risk, and difficulty of these treatment options are described in Table 4 . Because of the low prevalence of aggressive symptoms and the relatively high rates of spontaneous regression, it is suggested that the majority of cases be treated conservatively for 1-3 months (Fig 5) (3) . However, cases with progressive symptoms and dangerous drainage patterns require more aggressive treatment (TVE or TAE with n-butyl-2-cyanoacrylate), and cases that have remained stable for a few months should be treated with irradiation or intervention. One should also be aware that the low-risk drainage patterns of dural AVFs develop into high-risk patterns with progressive thrombosis or restriction of the cavernous sinus outlet (Fig 6) (37) .
TVE is the first-line curative therapy in cavernous sinus dural AVF. 
Techniques
Transfemoral Inferior Petrosal Sinus Route.-Although the inferior petrosal sinus often reveals complete occlusion, in most cases microcatheters can be introduced through the occluded sinus into the cavernous sinus (Fig 6) (38) . Vessel perforation with the guide wire and microcatheter during navigation through the occluded sinus is a rare but serious complication. Knowledge of the course of the inferior petrosal sinus and gentle and careful manipulation of the catheter-guide wire under "road map" guidance are important. Anterior Approach.-The second most common approach involves the transfemoral facial venous or superficial temporal venous access route (Fig 7) and the surgical superior ophthalmic venous access route (27,39 -42) . With the anterior approach, there is less risk of intracranial vessel perforation. Disadvantages of this approach include (a) the poor maneuverability of the catheter-guide wire due to the tortuous access route of the transfemoral approach and (b) the risk of superior ophthalmic vein injury.
Other Approaches.-Although the majority of cases of cavernous sinus dural AVF can be treated with the trans-inferior petrosal sinus approach or anterior approach, there are other potential approaches, such as the transsuperior petrosal sinus approach, the transcontralateral cavernous sinus approach, the transbasilar plexus approach, and the surgical cortical venous approach (43) (44) (45) . These less common approaches should be attempted when the two more common approaches are impossible or have failed.
Coil Embolization.-Outlets of the cavernous sinus to dangerous venous drainage systems (cortical reflux, deep venous drainage, anterior drainage) should be occluded immediately. Incomplete or inadequate embolization of dangerous venous outlets could increase venous hypertension. Before the coils are placed, it is important to determine whether a microcatheter can be introduced into all outlets of the cavernous sinus (Fig 6) . Furthermore, because the pressure in the remaining drainage veins will increase during embolization, the procedure should be kept as short as possible (46) . In this regard, the anterior approach is advantageous in that it allows embolization of the posterior part of the cavernous sinus first. In most cases, feeding artery shunts occur mainly in the posterior compartment of the cavernous sinus; therefore, embolization of this compartment first can reduce shunt flow and the risk of increasing venous pressure. After the occlusion of dangerous and symptomatic venous drainage systems, the cavernous sinus is embolized by placing coils mainly in the shunting portion. Dense packing of the cavernous sinus with coils should be avoided because of the risk of cranial nerve deficits due to compression of the cranial nerves by the coils (26, 46) .
Transverse-Sigmoid Sinus Dural AVFs
Although their most common symptoms are benign (pulsatile tinnitus and headache), transversesigmoid sinus dural AVFs are more frequently associated with hemorrhagic and nonhemorrhagic aggressive neurologic symptoms than are cavernous sinus dural AVFs (Table 1) (3,7,11 ). The risk of aggressive neurologic symptoms correlates well with the venous drainage pattern of transversesigmoid sinus dural AVFs. The classification system devised by Lalwani et al (11) is useful for predicting risk and determining the best treatment strategy. Grade 1 transverse-sigmoid sinus dural AVFs are characterized by antegrade sinus drainage without venous restriction or cortical venous reflux; Grade 2, by antegrade and retrograde sinus drainage with or without cortical venous reflux; Grade 3, by retrograde sinus drainage with cortical venous reflux; and Grade 4, by cortical venous reflux only (Fig 8) . Spontaneous regression of these AVFs is relatively rare (approximately 5% of cases) and usually occurs following hemorrhagic events (47) .
All transverse-sigmoid sinus dural AVFs are considered to require treatment because of the low rate of spontaneous regression without symptomatic events and the relatively high rate of aggressive symptoms. Treatment options include irradiation, surgical isolation or resection, TAE with particles or cyanoacrylate, and TVE. Recent studies of stereotactic radiation therapy for transverse-sigmoid sinus dural AVFs showed a relatively high occlusion rate of the AVF (approximately 60% of cases) several months after treatment without significant complications (17, 18) . Although TVE showed higher occlusion rates (80%-100% of cases), this procedure requires sacrifice of sinus flow and may cause venous infarction if the sinus contributes to the drainage of normal cerebral tissue (25, 48, 49) . The rate of permanent complications in TVE is approximately 4% (48, 49) . The efficacy, potential risk, and difficulty of the treatment options for transverse-sigmoid sinus dural AVFs are described in Table 5 , and a summary of strategies according to lesion grade is shown in Table 6 . In the treatment of Grade 2 lesions, occlusion of the normal cortical venous drainage system should be avoided. When there is a high risk of normal cortical venous drainage sacrifice at TVE, other treatments such as radiation therapy should be applied. Surgical isolation of the sinus with preservation of normal cortical venous drainage may also be performed but is more invasive. Grade 3 lesions can be treated with TVE, during which time the affected sinus and retrograde cortical drainage outlet should be tightly packed with coils. Loose packing might cause recanalization, resulting in delayed hemorrhagic infarction after embolization (Fig 9) . Although endovascular stent placement can restore antegrade sinus flow and close shunts within the sinus wall, only a few successful cases have been reported (31, 32) ; therefore, further investigation of the effectiveness of stent placement in the treatment of dural AVFs is necessary. Grade 4 lesions are the most difficult type of dural AVF to treat. The standard techniques combine endovascular and neurosurgical elements (eg, TVE combined with a surgical approach) (50 -52) . In patients in poor general condition, other techniques (eg, TVE combined with other approaches, TAE with n-butyl-2-cyanoacrylate) may be used; however, they require more skill (28) .
Tentorial Dural AVFs
Because tentorial dural AVFs drain only via the leptomeningeal vein, they carry a high risk of aggressive neurologic symptoms ( Table 1 ). The reported occurrence of intracranial hemorrhage ranges from 60% to 74%; in some cases, this hemorrhage consists of fatal bleeding in the posterior fossa (3). Treatment options include irradiation, surgical interruption of the draining vein with or without resection, TAE with cyanoacrylate, and TVE (a) TVE with either a surgical approach, an approach through the occluded sinus, or a transcortical venous approach; (b) TAE with n-butyl-2-cyanoacrylate; or (c) surgical resection or resection with preparatory TAE Complete occlusion (100)
*Surgery and TAE with n-butyl-2-cyanoacrylate are equal in terms of potential risk and technical difficulty; they are more potentially risky and technically difficult than radiation therapy and less so than TVE. † Numbers in parentheses indicate percentages of cases. (15, 18, 21, 29, 30, (53) (54) (55) (56) (57) (58) . The efficacy, potential risk, and difficulty of these options are described in Table 7 . Tentorial dural AVFs drain through the retrograde leptomeningeal-cortical venous drainage system only (Cognard types III and IV, Borden type III), resulting in a high risk of hemorrhagic or nonhemorrhagic aggressive symptoms (19% and 10% of cases per year, respectively).
Complete cure of such AVFs requires aggressive treatment. Interventional and surgical procedures are both used to disconnect the venous drainage system; however, because of the deep-seated location of such lesions, the difficult access route, and the need for n-butyl-2-cyanoacrylate (Fig 10) , these techniques require a high level of skill (53) (54) (55) . Treatment selection depends on the skill of the neurosurgeon and interventional radiologist and on lesion accessibility. Stereotactic radiosurgery should be considered an option, especially in older patients or in those in poor general condition (Fig 11) (15,18,21 ). 
Superior Sagittal Sinus Dural AVFs
Because superior sagittal sinus dural AVFs are frequently associated with restrictive change of the superior sagittal sinus and retrograde cortical venous drainage, aggressive neurologic symptoms are seen in one-half of cases (Table 1 ) (3). Venous congestion of the bilateral frontal lobes due to a superior sagittal sinus dural AVF can cause dementia, a rare but important symptom (59) . The dementia can be misdiagnosed as a psychogenic or degenerative disorder but can be cured after treatment of the dural AVF. The efficacy, potential risk, and difficulty of treatment options for superior sagittal sinus dural AVFs are described in Table 8 . These strategies are similar to those for treating transverse-sigmoid sinus dural AVFs. Superior sagittal sinus dural AVFs are more frequently associated with aggressive symptoms and therefore often require aggressive treatment. Superior sagittal sinus dural AVFs are strongly associated with superior sagittal sinus occlusion; therefore, the percutaneous transvenous approach is often difficult. Standard techniques include TVE with a surgical approach and surgical isolation or resection of the sinus (24, 51) . In some cases, superior sagittal sinus occlusion can be treated with transarterial intravenous catheterization and coil embolization via the middle meningeal artery (Fig 12) (60) . Although there have been few reports of the treatment of superior sagittal sinus dural AVFs with irradiation, the efficacy of radiation therapy in treating transverse-sigmoid sinus dural AVFs suggests that irradiation might be an effective treatment (16, 22) . 
Anterior Fossa Dural AVFs
Anterior fossa dural AVFs have a venous drainage pattern similar to that of tentorial dural AVFs with retrograde leptomeningeal drainage and are frequently associated with intracranial hemorrhage or nonhemorrhagic neurologic symptoms (Fig 13, Table 1 ) (3, 61, 62) . The efficacy, potential risk, and difficulty of the various treatment options for anterior fossa dural AVFs are described in Table 9 . Dural AVFs located on the anterior fossa drain through the retrograde leptomeningeal-cortical venous drainage system only (Cognard types III and IV, Borden type III), resulting in a high risk of hemorrhagic or nonhemorrhagic aggressive symptoms. A complete cure is necessary. However, these AVFs are always supplied by the bilateral ophthalmic arteries, in which catheterization is difficult and dangerous (33) . Few anterior fossa dural AVFs can be safely treated with TVE, since transvenous routes are also tortuous and often associated with venous aneurysms (63) . On the other hand, surgical approaches are relatively easy and safe; therefore, these AVFs should be treated with surgical disconnection of the venous drainage systems (33, 61) .
Other Dural AVFs
Dural AVFs can also occur at other locations, including the marginal sinus, inferior and superior petrosal sinuses, major sinus wall, and hypoglossal canal (64 -68) . The treatment strategy for these AVFs is also determined by the risk of aggressive symptoms and the efficacy of each technique, which depend on lesion accessibility and the skill of the neurosurgeon and interventional radiologist. Complete occlusion (100)
*TVE and TAE with n-butyl-2-cyanoacrylate are equal in terms of potential risk and technical difficulty; they are more potentially risky and technically difficult than surgery, which in turn is more so than radiation therapy. † Numbers in parentheses indicate percentages of cases.
Conclusions
In this article, we have discussed and illustrated current strategies in the treatment of dural AVFs according to location and venous drainage. Knowledge of drainage patterns and the risk of aggressive symptoms, as well as familiarity with recent technical advances, is essential for the treatment of intracranial dural AVFs.
